Transition state analogues in structures of ricin and saporin ribosome-inactivating proteins

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 48, 2009, Pages 20276-20281

  Ho, Meng Chiao ^a   Sturm, Matthew B ^a   Almo, Steven C ^a   Schramm, Vern L ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Depurination; Ricin toxin A chain; Saporin L1; Sarcin ricin loop

Indexed keywords

ADENINE; ARGININE; CATION; GLUTAMIC ACID; GUANINE; NUCLEOPHILE; PURINE; RIBOSOME INACTIVATING PROTEIN; RICIN; RNA 28S; SAPORIN; TYROSINE; WATER;

ARTICLE; CATALYSIS; CONTROLLED STUDY; CRYSTAL STRUCTURE; GEOMETRY; POLARIZATION; PRIORITY JOURNAL; RECOGNITION;

ARGININE; CRYSTALLIZATION; MODELS, MOLECULAR; MOLECULAR STRUCTURE; PURINES; RIBOSOME INACTIVATING PROTEINS; RIBOSOME INACTIVATING PROTEINS, TYPE 1; RICIN;

EID: 73949090667     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0911606106     Document Type: Article

References (44)

1. Endo Y, Mitsui K, Motizuki M, Tsurugi K (1987) The mechanism of action of ricin and related toxic lectins on eukaryotic ribosomes. The site and the characteristics of the modification in 28 S ribosomal RNA caused by the toxins. J Biol Chem 262:5908-5912.
2. Amlot PL, et al. (1993) A phase I study of an anti-CD22-deglycosylated ricin A chain immunotoxin in the treatment of B-cell lymphomas resistant to conventional therapy. Blood 82:2624-2633.
3. Messmann RA, et al. (2000)Aphase I study of combination therapy with immunotoxins IgG-HD37-deglycosylated ricin A chain (dgA) and IgG-RFB4-dgA (Combotox) in patients with refractory CD19(+), CD22(+) B cell lymphoma. Clin Cancer Res 6:1302-1313.
4. Sausville EA, et al. (1995) Continuous infusion of the anti-CD22 immunotoxin IgG-RFB4-SMPT-dgA in patients with B-cell lymphoma: A phase I study. Blood 85:3457-3465.
5. Senderowicz AM, et al. (1997) Complete sustained response of a refractory, post-transplantation, large B-cell lymphoma to an anti-CD22 immunotoxin. Ann InternMed 126:882-885.
6. Baluna R, Coleman E, Jones C, Ghetie V, Vitetta ES (2000) The effect of a monoclonal antibody coupled to ricinAchain-derived peptides on endothelial cells in vitro: Insights into toxin-mediated vascular damage. Exp Cell Res 258:417-424.
7. Soler-Rodriguez AM, Ghetie MA, Oppenheimer-Marks N, Uhr JW, Vitetta ES (1993) Ricin A-chain and ricin A-chain immunotoxins rapidly damage human endothelial cells: Implications for vascular leak syndrome. Exp Cell Res 206:227-234.
8. Ferreras JM, et al. (1993) Distribution and properties of major ribosome-inactivating proteins (28 S rRNA N-glycosidases) of the plant Saponaria officinalis L. (Caryophyllaceae). Biochim Biophys Acta 1216:31-42.
9. Stirpe F, et al. (1983) Ribosome-inactivating proteins from the seeds of Saponaria officinalis L. (soapwort), of Agrostemma githago L. (corn cockle) and of Asparagus officinalis L. (asparagus), and from the latex of Hura crepitans L. (sandbox tree). Biochem J 216:617-625.
10. Barbieri L, et al. (1997) Polynucleotide:adenosine glycosidase activity of ribosome-inactivating proteins: Effect on DNA, RNA and poly(A). Nucleic Acids Res 25:518-522.
11. Barbieri L, Valbonesi P, Gorini P, Pession A, Stirpe F (1996) Polynucleotide: Adenosine glycosidase activity of saporin-L1: Effect on DNA, RNA and poly(A). Biochem J 319(Pt 2):507-513.
12. Barbieri L, Valbonesi P, Govoni M, Pession A, Stirpe F (2000) Polynucleotide:adenosine glycosidase activity of saporin-L1: Effect on various forms ofmammalian DNA. Biochim Biophys Acta 1480:258-266.
13. Amukele TK, Roday S, Schramm VL (2005) Ricin A-chain activity on stem-loop and unstructured DNA substrates. Biochemistry 44:4416-4425.
14. Chen XY, Link TM, Schramm VL (1998) Ricin A-chain: Kinetics, mechanism, and RNA stem-loop inhibitors. Biochemistry 37:11605-11613.
15. Sturm MB, Schramm VL (2009) Transition state analogues rescue ribosomes from saporin-L1 ribosome inactivating protein. Biochemistry 48:9941-9948.
16. Gluck A, Endo Y, Wool IG (1992) Ribosomal RNA identity elements for ricin A-chain recognition and catalysis. Analysis with tetraloop mutants. J Mol Biol 226:411-424.
17. Sturm MB, Roday S, Schramm VL (2007) Circular DNA and DNA/RNA hybrid molecules as scaffolds for ricin inhibitor design. J Am Chem Soc 129:5544-5550.
18. Allerson CR, Verdine GL (1995) Synthesis and biochemical evaluation of RNA containing an intrahelical disulfide crosslink. Chem Biol 2:667-675.
19. Chen XY, Berti PJ, SchrammVL (2000) Transition-state analysis for depurination ofDNA by ricin A-chain. J Am Chem Soc 122:6527-6534.
20. Chen XY, Berti PJ, Schramm VL (2000) Ricin A-chain: Kinetic isotope effects and transition state structure with stem-loop RNA. J Am Chem Soc 122:1609-1617.
21. Robertus JD, Monzingo AF (2004) The structure of ribosome inactivating proteins. Mini-Rev Med Chem 4:477-486.
22. Monzingo AF, Robertus JD (1992) X-ray analysis of substrate analogs in the ricin A-chain active site. J Mol Biol 227:1136-1145.
23. Kim Y, Robertus JD (1992) Analysis of several key active site residues of ricin A chain by mutagenesis and X-ray crystallography. Protein Eng 5:775-779.
24. Kim Y, et al. (1992) Structure of a ricin mutant showing rescue of activity by a noncatalytic residue. Biochemistry 31:3294-3296.
25. Frankel A, Welsh P, Richardson J, Robertus JD (1990) Role of arginine 180 and glutamic acid 177 of ricin toxin A chain in enzymatic inactivation of ribosomes. Mol Cell Biol 10:6257-6263.
26. Sturm MB, Schramm VL (2009) Detecting ricin: A sensitive luminescent assay for ricin A-chain ribosome depurination kinetics. Anal Chem 81:2847-2853.
27. Olsnes S, Fernandez-Puentes C, Carrasco L, Vazquez D (1975) Ribosome inactivation by the toxic lectins abrin and ricin. Kinetics of the enzymic activity of the toxin A-chains. Eur J Biochem 60:281-288.
28. Korennykh AV, Piccirilli JA, Correll CC (2006) The electrostatic character of the ribosomal surface enables extraordinarily rapid target location by ribotoxins. Nat Struct Mol Biol 13:436-443.
29. Roday S, et al. (2004) Inhibition of ricin A-chain with pyrrolidine mimics of the oxacarbenium ion transition state. Biochemistry 43:4923-4933.
30. Savino C, Federici L, Ippoliti R, Lendaro E, Tsernoglou D (2000) The crystal structure of saporin SO6 from Saponaria officinalis and its interaction with the ribosome. FEBS Lett 470:239-243.
31. OlsonMA(1997) Ricin A-chain structural determinant for binding substrate analogues: A molecular dynamics simulation analysis. Proteins 27:80-95.
32. Versees W, Loverix S, Vandemeulebroucke A, Geerlings P, Steyaert J (2004) Leaving group activation by aromatic stacking: An alternative to general acid catalysis. J Mol Biol 338:1-6.
33. Mlsna D, Monzingo AF, Katzin BJ, Ernst S, Robertus JD (1993) Structure of recombinant ricin A chain at 2.3 A. Protein Sci 2:429-435.
34. Correll CC, Beneken J, Plantinga MJ, Lubbers M, Chan YL (2003) The common and the distinctive features of the bulged-G motif based on a 1.04 A resolution RNA structure. Nucleic Acids Res 31:6806-6818.
35. Correll CC, et al. (1998) Crystal structure of the ribosomal RNA domain essential for binding elongation factors. Proc Natl Acad Sci USA 95:13436-13441.
36. Jucker FM, Heus HA, Yip PF, Moors EH, Pardi A (1996) A network of heterogeneous hydrogen bonds in GNRA tetraloops. J Mol Biol 264:968-980.
37. Szewczak AA, Moore PB, Chang YL, Wool IG (1993) The conformation of the sarcin/ricin loop from 28S ribosomal RNA. Proc Natl Acad Sci USA 90:9581-9585.
38. Yang X, Gerczei T, Glover LT, Correll CC (2001) Crystal structures of restrictocininhibitor complexes with implications for RNA recognition and base flipping. Nat Struct Biol 8:968-973.
39. Parikh SS, et al. (2000) Uracil-DNA glycosylase-DNA substrate and product structures: Conformational strain promotes catalytic efficiency by coupled stereoelectronic effects. Proc Natl Acad Sci USA 97:5083-5088.
40. Lau AY, Wyatt MD, Glassner BJ, Samson LD, Ellenberger T (2000) Molecular basis for discriminating between normal and damaged bases by the human alkyladenine glycosylase, AAG. Proc Natl Acad Sci USA 97:13573-13578.
41. Bruner SD, Norman DP, Verdine GL (2000) Structural basis for recognition and repair of the endogenous mutagen 8-oxoguanine in DNA. Nature 403:859-866.
42. Mol CD, Arvai AS, Begley TJ, Cunningham RP, Tainer JA (2002) Structure and activity of a thermostable thymine-DNA glycosylase: Evidence for base twisting to remove mismatched normal DNA bases. J Mol Biol 315:373-384.
43. Carra JH, et al. (2007) Fragment-based identification of determinants of conformational and spectroscopic change at the ricin active site. BMC Struct Biol 7:72-82.
44. Miller DJ, et al. (2002) Structure-based design and characterization of novel platforms for ricin and shiga toxin inhibition. J Med Chem 45:90-98.